| Fri, 05 Jun 2020 12:25:23: | Stanford team deploys CRISPR gene editing to fight COVID-19
|
| Fri, 05 Jun 2020 11:50:46: | Melinta wins bidding war to land deal to acquire Tetraphase
|
| Fri, 05 Jun 2020 11:06:00: | After Kaletra setback, AbbVie joins forces with biotech, academia for experimental COVID-19 hopeful
|
| Fri, 05 Jun 2020 09:32:25: | Bristol's Celgene merger sees it bounce Jounce drug pact
|
| Thu, 04 Jun 2020 22:30:01: | Chutes & Ladders—WuXi adds Celgene vet Chang to head CAR-T offerings
|
| Thu, 04 Jun 2020 19:38:24: | What does it mean to #BeFierce? Our new look tells the story
|
| Thu, 04 Jun 2020 12:14:33: | GSK's cell therapy R&D lead jumps ship to partner Immatics
|
| Thu, 04 Jun 2020 12:11:27: | Broad Institute's new gene-editing technique restores hearing in mice
|
| Thu, 04 Jun 2020 10:25:18: | Spectrum Pharma nabs Five Prime, Gilead veteran as new clinical lead
|
| Thu, 04 Jun 2020 09:42:01: | Gilead shows durability of filgotinib ahead of face-off with AbbVie
|
| Wed, 03 Jun 2020 13:47:29: | Novellus snaps up BRAF cancer drug from Daiichi's biotech unit Plexxikon
|
| Wed, 03 Jun 2020 12:21:08: | Aduro, Chinook ink merger to take renal drug into phase 3
|
| Wed, 03 Jun 2020 10:21:47: | Gene-edited T cells to treat diabetes inch closer to clinical trials
|
| Tue, 02 Jun 2020 12:53:38: | In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center
|
| Tue, 02 Jun 2020 12:22:14: | Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority
|
| Tue, 02 Jun 2020 11:07:16: | Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis
|
| Tue, 02 Jun 2020 08:33:48: | Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs
|
| Mon, 01 Jun 2020 13:29:34: | I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm
|
| Mon, 01 Jun 2020 12:12:32: | Lilly starts first clinical trial of COVID-19 antibody therapy
|
| Mon, 01 Jun 2020 11:56:29: | Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost
|
| Mon, 01 Jun 2020 11:28:07: | AbbVie pens cancer pact with U.S.-China biotech Jacobio
|
| Mon, 01 Jun 2020 10:40:14: | Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action
|
| Fri, 29 May 2020 12:56:34: | ASCO: Allogene reports 63% response rate in early trial of off-the-shelf CAR-T in lymphoma
|
| Fri, 29 May 2020 11:06:30: | Takeda culls Shire pipeline med after no one wants it
|
| Fri, 29 May 2020 08:12:21: | Ipsen names Sanofi Pasteur CEO Loew as new leader
|
